INNO News - Candlesense

Innocan Pharma Announces Details of Proposed Share Consolidation

(INNO) HERZLIYA, Israel and CALGARY, Alberta, Aug. 29, 2025 /PRNewswire/ -- Innocan Pharma Corporation ("Innocan" or the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that...

When is the consolidation expected to be executed and what regulatory filings are required? How will the consolidation affect the company’s liquidity and free float? What will be the immediate market reaction to the share consolidation announcement?

Share split

18 days ago

Innocan Pharma Announces First Half Of 2025 Financial Results

HERZLIYA, Israel and CALGARY, AB, Aug. 27, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focu...

Did the update include any new milestones or partnerships for the drug delivery platform that could affect growth forecasts? What revisions, if any, were provided to the company's 2025 cash‑runway and future financing plans? How did the half‑year revenue and net loss compare to analysts' expectations?

Earnings

20 days ago

Innocan's Findings to be Showcased in Scientific Poster Reception at PAINWeek 2025 Conference in Las Vegas, Nevada

PAINWeek is the premier US conference in pain management Innocan's Poster "Is Long-Acting Synthetic Cannabidiol a Solution to Chronic Pain?" to be highlighted HERZLIYA, Israel and CALGARY, AB, Aug....

Clinical trials

25 days ago